20 assets in Precursor Lymphoblastic Lymphoma/Leukemia

Therapeutic assets addressing Precursor Lymphoblastic Lymphoma/Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dexasone Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (63)
Cyclophosphamide Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (60)
Cytarabine Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
Mercaptopurine Anhydrous Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
Pegaspargase Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
Prednisone Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
(+)-Vincristine Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (57)
Bifidobacterium Bifidum Precursor Lymphoblastic Lymphoma/Leukemia	National Institute of Pediatrics, Mexico	P2	CCC (53)
Blinatumomab Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
Daunomycin Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
Inotuzumab Ozogamicin Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
Lactobacillus Rhamnosus Precursor Lymphoblastic Lymphoma/Leukemia	National Institute of Pediatrics, Mexico	P2	CCC (53)
Venetoclax Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (53)
Methotrexate Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (52)
Allogeneic Cart-Nkg2D Cells Precursor Lymphoblastic Lymphoma/Leukemia	Instituto de Investigación Hospital Universitario La Paz	P1	CC (41)
cd22 car-transduced t cells Precursor Lymphoblastic Lymphoma/Leukemia	Instituto de Investigación Hospital Universitario La Paz	P1	CC (41)
int2104 Precursor Lymphoblastic Lymphoma/Leukemia	Kite, A Gilead Company	P1	CC (41)
Turalio Precursor Lymphoblastic Lymphoma/Leukemia	National Cancer Institute (NCI)	P1	CC (41)
Autologous Car123 T Lymphocytes Precursor Lymphoblastic Lymphoma/Leukemia	Institute of Hematology and Blood Transfusion, Czech Republic	Early P1	C (38)
Dasatinib Precursor Lymphoblastic Lymphoma/Leukemia	First Affiliated Hospital Xi'an Jiaotong University	N/A	D (30)